Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    11134183 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Allergy Immunotherapy in the Management of Eosinophilic Esophagitis
Condition: Eosinophilic Esophagitis
Intervention: Biological: Allergy immunotherapy ("allergy shots")

Indicates status has not been verified in more than two years